Results 121 to 130 of about 10,049 (144)

Postmarketing Cases of Erdafitinib-Associated Skeletal Growth Toxicity Events in Pediatric Patients. [PDF]

Pediatr Blood Cancer
Nadeau Nguyen M, Dores GM, Nayernama A, Jones SC.   +3 more
europepmc   +1 more source

Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan. [PDF]

Front Psychiatry
Takekita Y, Umeyama M, Iwaida M, Higashikawa M, Shimada Y, Nakajima A.   +5 more
europepmc   +1 more source

Case Study on the Use of Real-World Evidence in a Feasibility Assessment of a Randomized Controlled Trial Design to Support the Fulfillment of Pediatric Requirements with the FDA and EMA. [PDF]

Ther Innov Regul Sci
Storm NE, Kubik C, Priem G, Kim M, Lin TC, Lange J, O'Connell C, Glennane A, Bradbury BD, Taisey MJ.   +9 more
europepmc   +1 more source

Controversial efficacy of antithrombin followed by recombinant thrombomodulin administration in patients with sepsis-induced disseminated intravascular coagulation: an analysis of postmarketing surveillance data. [PDF]

Thromb J
Eguchi Y, Nagafuchi H, Ikeda T.
europepmc   +1 more source

Comment on Wei et al. [PDF]

Pediatr Allergy Immunol
Lei WT, Weng SL, Lin CY.
europepmc   +1 more source

Comprehensive Analysis of Ozanimod-Related Adverse Events Based on the FAERS Database. [PDF]

World J Oncol
Zhou ZR, Zhou QY, Shen Y, Zhao XY, Zhan Q, Sun J, Chen ZX.   +6 more
europepmc   +1 more source

Current Status of the Safety and Efficacy of Antidotes for Direct Oral Anticoagulants in Japan. [PDF]

JACC Asia
Kodani E.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018

Clinical Trials, 2021
Audrey Zhang, Joshua D Wallach, Joshua Skydel   +2 more
exaly  

Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data

Headache, 2021
David Dodick
exaly  

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2011
Yoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi   +2 more
exaly   +2 more sources